Aromatase as a therapeutic target in endometriosis
Review
OA: closed
CC0
⤵ 30 in-corpus citations
AI-generated summary
This paper investigates aromatase as a potential therapeutic target for endometriosis, exploring its role in the disease and potential treatment strategies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
In contrast to normal endometrium, the expression of aromatase is aberrant in endometriosis and is stimulated by prostaglandin E2 (PGE2). This results in local production of estrogen, which induces PGE2 formation and establishes a positive feedback cycle. Another abnormality in endometriosis--deficient 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) type 2 expression--impairs the inactivation of estradiol (E2) to estrone (E1). These molecular aberrations collectively favor accumulation of increasing quantities of E2, and PGE2 in endometriosis. The clinical relevance of these findings was exemplified by the successful treatment of an unusually aggressive case of postmenopausal endometriosis with an aromatase inhibitor.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (44)
- Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis via openalex
- Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992 via openalex
- Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol via openalex
- Deficient 17 -Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17 -Estradiol via openalex
- Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? via openalex
- Endometriosis via openalex
- Epidemiology of endometriosis in women attending family planning clinics via openalex
- Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content via openalex
- Immunology and endometriosis via openalex
- Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1) via openalex
- Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1) via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice via openalex
- Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex
- W6679368533 via openalex
- W1507820521 via openalex
- W6687973442 via openalex
- W1512318310 via openalex
- W1980385764 via openalex
- W1987557870 via openalex
- W2002196249 via openalex
- W2012313039 via openalex
- W2013857643 via openalex
- W2038138852 via openalex
- W2039144212 via openalex
- W2047317603 via openalex
- W2068935255 via openalex
- W2069877703 via openalex
- W2073595123 via openalex
- W2099423538 via openalex
- W2126100083 via openalex
- W2130996329 via openalex
- W2149383746 via openalex
- W4234889952 via openalex
- W4253097306 via openalex
- W4285719527 via openalex
- W6675112554 via openalex
Cited by (31)
- Molecular Insights Into Endometriosis for Early Detection and Therapeutic Targets 2026
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Aberrant epigenetic regulation of estrogen and progesterone signaling at the level of endometrial/endometriotic tissue in the pathomechanism of endometriosis 2022
- Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis 2021
- A pilot randomised double blind controlled trial of the efficacy of purified fatty acids for the treatment of women with endometriosis-associated pain (PurFECT): study protocol 2018
- Functional Expression of FSH Receptor in Endometriotic Lesions 2016
- Etude phénotypique des cellules endométriosiques profondes 2012
- Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons 2012
- [Endometriosis: aetiopathogenetic basis] 2011
- Endometriosis: Aetiopathogenetic Basis 2010
- Useful Biomarkers for the Diagnosis of Endometriosis 2010
- Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo 2010
- Estrogen metabolizing enzymes in endometrium and endometriosis 2007
- Alternative Therapieoptionen bei Endometriose 2007
- Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis? 2007
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy 2007
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers? 2005
- Aromataseinhibitoren bei Endometriose? 2004
- [P450Arom and estrogenic microenvironment of eutopic endometria in endometriosis] 2004
- Endometriose 2004
- Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis 2004
- Serum and Peritoneal Markers for Endometriosis 2003
- The molecular basis for implantation failure in endometriosis: on the road to discovery 2002
- Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues 2002
- Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells 2002
- Molecular mechanisms contributing to the pathogenesis of endometriosis 2002
- Aromatase und Cyclooxygenase-2 – neue Ansätze in der Endometriosetherapie? 2002
- Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues 2002
- High omega-3:omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis 2001
Source provenance
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T20:59:14.592962+00:00
License: CC0
· commercial use OK